How GPCR genetic variants shape psychiatric drug response - Hauser on pharmacogenomics, the iPSYCH biobank Hauser: GPCR Pharmacogenomics and Precision Psychiatry GPCR drug targets carry genetic variation that Hauser's research program asks a pointed question: if a patient fails to respond to a psychiatric drug About the Guest Alexander Hauser is a postdoctoral researcher at the University of Copenhagen's Department Hauser Alexander is currently a postdoc as a member of the personalized medicine cluster in Copenhagen

Alexander Hauser and colleagues, is the motivating tension behind Dr. GPCR. Alexander Hauser , and Luise Wagner .

<< Back to podcast list Strategic Partner(s) Nicole Perry-Hauser About Nicole (Nicki) Perry-Hauser I Nicole (Nicki) Perry-Hauser on the web LinkedIn Research Gate Pubmed Dr.

this episode Listen to this fantastic round table discussion that I had the privilege to moderate with Alexander Hauser .

Pharmacogenomic variation in GPCRs may already be shaping clinical drug response - unacknowledged A paper by Hauser cell-type dependence, and allosteric complexity 32:08 GPCR pharmacogenomics - variant receptors, the Hauser

Chia-Yi Lin and Alexander Ball, both scientists-turned-industry professionals at GeneTex, trace how the ABOUT THE GUESTS Alexander Ball is a senior scientist at GeneTex who joined the company in 2012 after Alexander Ball "You really don't understand antibodies until you're in the industry. Alexander Ball "It's defined by the primary sequence. It's there. It's in a plasmid. Alexander Ball, on recombinant monoclonal antibodies Unlock the Full Dr.

Alexander Ball of GeneTex on the recombinant platform and validation strategy behind a challenge to GPCR Alexander Ball , MD, Senior Scientist, GeneTex, Inc. Dr.

Alexander Ball, MD Dr. Alexander Ball of GeneTex joins Dr.